American pharmaceutical firm to invest in Penangwhere2life | June 25, 2020 | 0 | News
More employment opportunities will be available in the state following the US based DexCom, INC., a global leader in continuous glucose monitoring (CGM) system’s decision to set-up a new factory at the Batu Kawan Industrial Park in Penang.
Penang Chief Minister Chow Kon Yeow, said the state was proud that Dexcom would be investing on a new 28-acre site for its first facility here this year.
“Dexcom looked beyond the current macro uncertainties. It has chosen to invest in Penang despite the current Covid-19 pandemic.
“Dexcom’s new facility will be focusing on the manufacturing of sensors and applicators for the CGM system. Construction works are expected to begin in the second half of this year.
“The new manufacturing facility also will create significant job additions over the next 10 years, including roles in manufacturing, facilities management as well as manufacturing-related research and development (R&D).
“It will also mark Penang’s meaningful participation in the CGM field, and I am proud to share that this will be Dexcom’s third plant and its maiden manufacturing facility outside of the United States,” Chow told a press conference in Komtar.
“With over 50 medical device companies present in the state, Penang’s medical devices cluster is among the highest concentration in Southeast Asia.
“We benefit from this because Dexcom CGM systems require expertise and support from electronics engineering, manufacturing and related ancillary services, which are already well-established in Penang.
“The state government will also continue to entrench Penang’s position in the medical technology industry,” he added.
Chow also thanked the Malaysian Investment Development Authority (Mida) for working closely with investPenang in attracting high-quality investments to Penang.
“I would like to congratulate Dexcom for this significant expansion here in Penang and Malaysia; and I look forward to fostering a close partnership with Dexcom. I assure the state’s commitment in facilitating and driving the project to success,” Chow added.
Dexcom, Inc., is a company that develops, manufactures, and distributes CGM systems for diabetes management. It operates internationally and headquartered in the United States.
Source – Buletin Mutiara